About Nevoa Life Sciences Holdings
Nevoa Life Sciences Holdings is a private company based in Gilbert, Arizona. It has reported $16,441,028 raised in four offerings on Form D since August 2018. Its chief executive is Martin McGonagle.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 19, 2024 | Jan 13, 2025 | $5,892,851of $5.9M target | 5 | $1.1M | EquityRule 506(b) | Form D ↗ |
| Jan 1, 2022 | Mar 3, 2022 | $6,163,027of $12.0M target | 4 | $1.5M | EquityRule 506(b) | Form D ↗ |
| Jul 23, 2019 | Aug 2, 2019amended Nov 18, 2019 | $2,880,150target not set | 10 | $288K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 20, 2018 | Aug 3, 2018amended Nov 13, 2018 | $1,505,000fully sold | 11 | $136K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, four offerings | $16,441,028 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Nevoa Life Sciences Holdings's Form D filed Jan 13, 2025.
BE
Brad Edwards
Director
TB
Tim Barone
Director
MH
Mike Hudson
Director
LL
Lou Laskis
Director
SA
Sanan Abhay
Director
MM
Martin McGonagle
Chief Executive Officer and director
JD
Joe Damico
Director
EC
Ernest Cunningham
President and Chief Operating Officer
DB
Dan Bueschel
Director
Earlier filings also listed Louis Laskis (director, last listed Mar 2022), Allen Arroyo (cfo, last listed Mar 2022), Robert Hart (director, last listed Nov 2019) and Charles Risley (director, last listed Nov 2018).